Dec 01, 2021 2:45pm EST 180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynote Address at the 2021 International Dupuytren Symposium, Including Top Line Data From the Phase 2b Clinical Trial
Nov 18, 2021 8:15am EST 180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Keynote Address at the 2021 International Dupuytren Symposium
Nov 03, 2021 12:06pm EDT 180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer
Oct 26, 2021 8:30am EDT 180 Life Sciences Corp. Publishes Pre-Clinical Study Report on the Effects of CBG Derivatives on Pain, Inflammation and Obesity in The Journal Molecules
Sep 20, 2021 8:00am EDT Celltrion Healthcare and 180 Life Sciences Enter Into Memorandum of Understanding for a Supply Agreement for the Ongoing Supply of Drug for Anti-TNF Product Trials for Novel Indications
Aug 30, 2021 8:30am EDT 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders